Thinking of joining a study?

Register your interest

NCT04717427 | RECRUITING | Sturge-Weber Syndrome


Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
Sponsor:

University of Illinois at Chicago

Information provided by (Responsible Party):

Jeffrey A Loeb

Brief Summary:

Individuals with Sturge-Weber Syndrome (SWS) sometimes have brain involvement which can result in seizures, stroke-like episodes and neurologic deficits. The purpose of this study is to integrate longitudinal clinical data, radiological data, and blood biomarkers of Sturge-Weber syndrome patients. The research aims are: 1. To integrate longitudinal clinical data, radiological data, and blood biomarkers of Sturge-Weber syndrome patients. 2. Identify plasma and imaging biomarkers sensitive to exacerbation of clinical symptoms including seizures, headaches, or stroke-like episodes. 3. For enrolled patients who present with severe neurological symptoms screen blood samples for inflammatory changes. The target enrollment for this study is about 250 individuals diagnosed with Sturge-Weber Syndrome. The goal of this study is to understand more about Sturge-Weber Syndrome, the possible treatments for this disease, and identify targets for clinical trials. Those participating in the database will be asked to consent to blood draws.

Condition or disease

Sturge-Weber Syndrome

Detailed Description:

Aim 1: Develop a longitudinal database of patients with SWS Clinical sites will collect longitudinal data retrospectively on measures of clinical symptoms and medications/treatments for study subjects who participated in the existing BVMC2/SWF registry and consent to participate in BVMC3 study. Retrospective data will be used to create a longitudinal dashboard where practitioners can identify predictors of atrisk patients who are most likely to have a serious neurological symptom and the current treatments. Prospective data collection: Clinical sites will collect longitudinal data prospectively for at-risk patients who present with a new, severe neurological symptom. Aim 2: Examine longitudinal Quantitative MRI Baseline MRI datasets will be collected and Limited Data Sets (LDS) will be generated and uploaded to a central imaging database from all participating centers. Subsequent MRI scans will be collected for patients who experience acute exacerbation of clinical symptoms, including seizures, headaches, or stroke-like episodes. Integrated imaging data, detailed treatment data, and detailed clinical data including neurological symptoms, seizures, and headache history will be analyzed. Aim 3: Collect and Store Blood Samples for Analysis All patients enrolled in BVMC3 study will have blood samples sent to and stored at University of California San Francisco (UCSF). Enrolled patients presenting with stroke-like episodes, stroke, headache, or seizure will have a second blood sample taken at the time of the neurologic symptom and a third sample taken 6 months later, or even later if symptoms have not resolved within 6 months. Multiplex angioma and inflammatory marker array will be assessed on all 3 samples from patients at the same time.

Study Type : OBSERVATIONAL
Estimated Enrollment : 250 participants
Official Title : Integrated Longitudinal Studies to Identify Biomarkers and Therapeutic Strategies for Sturge-Weber Syndrome
Actual Study Start Date : 2021-09-08
Estimated Primary Completion Date : 2025-06-30
Estimated Study Completion Date : 2025-06-30

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * Patients with MRI-documented unilateral or bilateral leptomeningeal angiomas with or without neurological symptoms including seizures, headaches, and stroke-like episodes
  • * Patients of any age
  • * Availability of longitudinal clinical and imaging data from all patient EHR records
  • * Consent to being followed prospectively throughout the course of the study
  • * Willing to provide blood samples
  • * Inclusion criteria to trigger entry into Aim 1B: severe seizures, headaches, or stroke-like episodes
Exclusion Criteria
  • * Persons without physician diagnosed SWS
  • * Persons unwilling to sign informed consent

Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome

Location Details

NCT04717427


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, California

University of California San Francisco

San Francisco, California, United States, 94143

RECRUITING

United States, Illinois

University of Illinois At Chicago

Chicago, Illinois, United States, 60607

RECRUITING

United States, Maryland

Kennedy Krieger Institute

Baltimore, Maryland, United States, 21213

RECRUITING

United States, Massachusetts

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

RECRUITING

United States, Road cancer

Wayne State University

Detroit, Road cancer United States, 48202

RECRUITING

United States, New Mexico

University of New Mexico

Albuquerque, New Mexico, United States, 87106

RECRUITING

United States, Ohio

Cincinnati Children's Hospital

Cincinnati, Ohio, United States, 45229

RECRUITING

United States, Ohio

Nationwide Children's Hospital

Columbus, Ohio, United States, 43205

Loading...